The proteomics of pediatric brain tumors

References

• Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010;10(5):319-31
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos AK, Tsiliki G, Spyrou G, et al. Bioinformatics approaches in the discovery and understanding of reproduction-related biomarkers. Expert Rev Proteomics 2011;8(2):187-95
   PubMed Web of Science ®Google Scholar
• Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-7
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Wang H, et al. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003;100:13537-42
   PubMed Web of Science ®Google Scholar
• Ginestier C, Charafe-Jauffret E, Bertucci F, et al. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol 2002;161:1223-33
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rochon Y, Franza BR, et al. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-30
   PubMed Web of Science ®Google Scholar
• Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003;100:14229-34
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 2002;1(9):683-95
   PubMed Web of Science ®Google Scholar
• Cravatt BF, Simon GM, Yates JR III. The biological impact of mass-spectrometry-based proteomics. Nature 2007;450(7172):991-1000
   PubMed Web of Science ®Google Scholar
• Gstaiger M, Aebersold R. Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat Rev Genet 2009;10(9):617-27
   PubMed Web of Science ®Google Scholar
• Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 2010;11(6):427-39
   PubMed Web of Science ®Google Scholar
• Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008;6:675-84
   PubMed Web of Science ®Google Scholar
• Blaney SM, Kun LE, Hunter J, et al. Tumours of the central nervous system. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins;2006;786-864
   Google Scholar
• Kennedy C, Bull K, Chevignard M, et al. PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E). Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. Int J Radiat Oncol Biol Phys 2014;88(2)):292-300
   Google Scholar
• Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of pre-radiation chemotherapy versus radiotherapy alone for non-metastatic medulloblastoma: the international society of paediatric oncology/United Kingdom children’s cancer study group PNET-3 study. J Clin Oncol 2003;21(8):1581-91
   PubMed Web of Science ®Google Scholar
• Merchant TE, Fouladi M. Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 2005;75:287-99
   PubMed Web of Science ®Google Scholar
• Aktug T, Hakguder G, Sarioglu S, et al. Sacrococcygeal extraspinal ependymomas: the role of coccygectomy. J Pediatr Surg 2000;35:515-18
   PubMed Web of Science ®Google Scholar
• Hirahara F, Yamanaka M, Miyagia E, et al. Pure ovarian ependymoma: report of a case treated with surgery, chemotherapy, irradiation and hyperthermotherapy. Eur J Obstet Gynecol Reprod Biol 1997;75:221-3
   Google Scholar
• Zheng PP, Luider TM, Pieters R, et al. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors. J Neuropathol Exp Neurol 2003;62:855-62
   PubMed Web of Science ®Google Scholar
• Bertucci F, Birnbaum D, Goncalves A. Proteomics of breast cancer: principles and potential clinical applications. Mol Cell Proteomics 2006;5(10):1772-86
   Google Scholar
• Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 2008;118(5):1739-49
   PubMed Web of Science ®Google Scholar
• Jones DT, Kocialkowski S, Liu L, et al. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009;28(20):2119-23
   PubMed Web of Science ®Google Scholar
• Langen H, Berndt P, Röder D, et al. Two-dimensional map of human brain proteins. Electrophoresis 1999;20(4-5):907-16
   PubMed Web of Science ®Google Scholar
• Lubec G, Krapfenbauer K, Fountoulakis M. Proteomics in brain research: potentials and limitations. Prog Neurobiol 2003;69(3):193-211
   Google Scholar
• Carrette O, Demalte I, Scherl A, et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer’s disease. Proteomics 2003;3:1486-94
   PubMed Web of Science ®Google Scholar
• Zheng P, Luider TM, Pieters R, et al. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors. J Neuropathol Exp Neurol 2003;62:855-62
   PubMed Web of Science ®Google Scholar
• Rajagopal MU, Hathout Y, MacDonald TJ, et al. Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics 2011;11(5):935-43
   PubMed Web of Science ®Google Scholar
• de Bont JM, den Boer ML, Reddingius RE, et al. Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling. Clin Chem 2006;52(8):1501-9
   Google Scholar
• Walker DA, Punt JA, Sokal M. Clinical management of brain stem glioma. Arch Dis Child 1999;80(6)):558-64
   Google Scholar
• Saratsis AM, Yadavilli S, Magge S, et al. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 2012;14(5):547-60
   PubMed Web of Science ®Google Scholar
• Peyrl A, Krapfenbauer K, Slavc I, et al. Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles. Proteomics 2003;3(9):1781-800
   Google Scholar
• Gruber-Olipitz M, Ströbel T, Chen WQ, et al. Synthesis, chaperoning, and metabolism of proteins are regulated by NT-3/TrkC signaling in the medulloblastoma cell line DAOY. J Proteome Res 2008;7(5):1932-44
   Google Scholar
• Azizi AA, Gelpi E, Yang JW, et al. Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY. Cancer Lett 2006;241(2):235-49
   Google Scholar
• Gruber-Olipitz M, Yang JW, Stroebel T, et al. The medulloblastoma cell line DAOY but not eleven other tumor cell lines expresses minichromosome maintenance protein 4. Cancer Lett 2006;238(1):76-784
   Google Scholar
• Azizi AA, Li L, Ströbel T, et al. Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med. Amino Acids 2012;42(6):2149-63
   Google Scholar
• Epple LM, Griffiths SG, Dechkovskaia AM, et al. Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One 2012;7(7):e42064
   PubMed Web of Science ®Google Scholar
• de Bont JM, den Boer ML, Kros JM, et al. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis. J Neuropathol Exp Neurol 2007;66(6):505-16
   Google Scholar
• Anagnostopoulos AK, Dimas KS, Papathanassiou C, et al. Proteomics studies of childhood pilocytic astrocytoma. J Proteome Res 2011;10(5):2555-65
   PubMed Web of Science ®Google Scholar
• Nazarian J, Santi M, Hathout Y, Macdonald TJ. Protein profiling of formalin-fixed paraffin- embedded tissue: identification of potential biomarkers for pediatric brainstem glioma. Proteomics Clin Appl 2008;2(6):915-24
   Google Scholar
• Gimenez M, Souza VC, Izumi C, et al. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics 2010;10(15):2812-21
   Google Scholar
• Khwaja FW, Reed MS, Olson JJ, et al. Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res 2007;6:559-70
   PubMed Web of Science ®Google Scholar
• Radman I, Greiss S, Chin JW. Efficient and rapid C. elegans transgenesis by bombardment and hygromycin B selection. PLoS One 2013;8(10)):e76019
   Google Scholar
• Arndt V, Lacour B, Steliarova-Foucher E, et al. Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas. Ann Oncol 2007;18:1722-33
   Google Scholar